Bio-cognitive Cut-Points Differentiate Risk vs. No Risk for Prodromal Parkinson Cognition in Young Post-mTBI Veterans and Non-mTBI Controls
Vicki A. Nejtek, Rachel James, Gary Boehm, Helene Alphonso et autres
0 citationsmedRxiv
Parkinson's Institute and Clinical Center
Sunnyvale · US · nonprofit
491Publications signalées
139066Citations signalées
12Thèmes principaux
Principaux domaines
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNuclear Receptors and SignalingNeurological diseases and metabolismNicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorGenetic Neurodegenerative DiseasesBotulinum Toxin and Related Neurological DisordersReceptor Mechanisms and SignalingParkinson's Disease and Spinal DisordersAlzheimer's disease research and treatments
Évolution annuelle
Publications récentes
Preservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson’s Model: Selective Compensation Restricted to Substantia Nigra
Ashley Galfano, Robert McManus, Walter Navarrete, Sampada Chaudhari et autres
1 citationInternational Journal of Molecular Sciences
Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study
Rajesh Pahwa, Stuart H. Isaacson, D Cella, Sandeep Thakkar et autres
0 citationsClinical Parkinsonism & Related Disorders
Combined normalized raw datasets of Luciferase assays on SNCA conserved elements
Lori Sterling, Michael Walter, Dennis Ting, Birgitt Schüle
0 citations
Editorial: Translational research advancements utilizing the Iowa Gambling Task in preclinical and clinical studies: 30 years of the IGT
Vicki A. Nejtek, Michael F. Salvatore
0 citationsFrontiers in Psychiatry
Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation in Parkinson's Disease: A Randomised, Double-Blind, Crossover Pilot Trial
Ioannis U. Isaias, Sara Marceglia, Linda Borellini, Enrico Mailland et autres
0 citationsSSRN Electronic Journal
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update
Kevin McFarthing, Sue Buff, Gary Rafaloff, Kenneth Pitzer et autres
116 citationsJournal of Parkinson s Disease
Genome-wide association analysis identifies PLA2G4C as a susceptibility locus for Multiple System Atrophy
Shoji Tsuji, Yasuo Nakahara, Jun Mitsui, Hidetoshi Date et autres
0 citationsResearch Square
Delivering Multidisciplinary Rehabilitation Care in Parkinson’s Disease: An International Consensus Statement
Jennifer G. Goldman, Daniele Volpe, Terry D. Ellis, Mark A. Hirsch et autres
82 citationsJournal of Parkinson s Disease
Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol
Marie‐Louise Zeissler, Timothy Boey, Danny Chapman, Gary Rafaloff et autres
2 citationsBMJ Open
Predictive value of abbreviated olfactory tests in prodromal Parkinson disease
Pavan A. Vaswani, James F. Morley, Danna Jennings, Andrew Siderowf et autres
10 citationsnpj Parkinson s Disease
Genome-wide association study identifies a new susceptibility locus in PLA2G4C for Multiple System Atrophy
Yasuo Nakahara, Jun Mitsui, Hidetoshi Date, Kristine Joyce L. Porto et autres
9 citationsmedRxiv
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.